Econostrum on MSN
FDA flags serious insulin device risk that could lead to life-threatening complications
The U.S. Food and Drug Administration (FDA) has classified Insulet Corporation’s recall of certain Omnipod insulin delivery ...
The U.S. Food and Drug Administration (FDA) has designated Insulet Corp.’s PODD recall of certain Omnipod insulin delivery ...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Insulet ( (PODD)) just unveiled an update. On May 26, 2026, Insulet announced a ...
Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA alerted. This ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod ...
Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.
Insulet Corporation has issued a voluntary recall affecting approximately 7 million Omnipod insulin pods due to a manufacturing defect. The product defect involves a small tear in the device's tubing ...
Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results